April 21, 2026
Ray Therapeutics
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
- Round
- Series B
- Amount raised
- $125M
- Lead investor
- 4BIO Capital
- Industry
- Biotechnology
- Headquarters
- San Diego, United States
- Employees
- 11-50
- Website
- raytherapeutics.com
- View profile →
Other investors
- California Institute for Regenerative Medicine
- Janus Henderson Investors
- Novo Holdings
Source: Crunchbase snapshot 2026-05-15